abstract |
Disclosed are quinoxaline compounds of formula (I), or pharmaceutically acceptable salts thereof, wherein W is a piperidine or a piperazine moiety and the rest of the substituents are disclosed within the specification. Also disclosed is the use of the said compound in the manufacture of a medicament for treating cancer in a mammal. |